Status: Recruiting
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
The trial is performed to assess efficacy and safety of Beltavac with polymerized extract of house dust mites in allergic Rhinoconjunctivitis associated or not with asthma
Participants needed: 350
Trial details
Phase: Phase 3Age: 12-65Biological sex: AllType: InterventionalSponsor: Probelte Pharma S.L.U.Updated: Jul 18, 2024Locations: 18
Eligibility criteria
Written informed consent, signed and duly dated. [+5]
Concomitant sensitization to allergens other than dust mites if clinically relev... [+12]